EVENTS · VTRS
PEERS
EARNINGS
Viatris Inc. is a global healthcare company that develops, manufactures, and markets prescription medicines across a broad range of therapeutic areas. Its portfolio includes branded medicines, generic drugs, complex generics, and biosimilars, serving patients and healthcare providers in developed and emerging markets. The company also supplies active pharmaceutical ingredients used in pharmaceutical manufacturing and supports access to medicines through broad commercial and distribution capabilities. Viatris Inc. operates across regions including North America, Europe, Greater China, Japan, Australia, New Zealand, Latin America, Africa, and the Middle East. Its products address conditions in areas such as cardiovascular health, infectious diseases, central nervous system disorders, immunology, and oncology. By combining established brands with off-patent and technically complex medicines, Viatris Inc. occupies an important role in the global pharmaceutical market, helping manufacturers, healthcare systems, and patients access a wide range of essential treatments.
Moving with specialty and generic drug manufacturers
| Series | 1W | 1M |
|---|---|---|
| VTRS | +2.6% | +9.7% |
| Peers | +2.3% | +7.4% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 38 | 56 |
| QUARTER | EPS EST | EPS ACTUAL | EPS SURPRISE | REACTION |
|---|---|---|---|---|
| Q2 FY2026 | 0.61 | 0.69 | +12.58% | — |
| Q1 FY2026 | 0.51 | 0.59 | +15.17% | +7.65% |
| Q4 FY2025 | 0.54 | 0.57 | +4.82% | −7.15% |
| Q3 FY2025 | 0.63 | 0.67 | +5.83% | −5.86% |
| Series | 1W | 1M |
|---|---|---|
| VTRS | +2.6% | +9.7% |
| Peers | +2.3% | +7.4% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 38 | 56 |
